HIGHLIGHTS
- who: Ziran Wang from the Department of Clinical Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China have published the research: Clinical impact of the PAI-1 4G/5G polymorphism in Chinese patients with venous thromboembolism, in the Journal: (JOURNAL)
- what: The aim of this study was to elucidate the clinical impact of the PAI-1 4G/5G in Chinese patients with VTE. The authors evaluated the accuracy of TaqManMGB RT-PCR method for the identification of FVL and PAI-1 4G/5G polymorphisms, using sequencing method as the gold standard . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.